Botox maker Allergan have rebounded since its earnings report this week, but one trader sees a limit to further gains.
A trader sold 3,400 December 95 calls for $1.15, according to optionMONSTER's tracking systems. The previous open interest was just 97 contracts, so this is a new position.
The options were likely sold against an existing long position in the stock in a covered call trade. This strategy would be bullish up to the $95 strike price but not beyond, as it gives up any upside in the shares beyond that level. (See our Education section)
AGN is up 1.13 percent to $91.81 this morning. The stock dipped near $86 on Wednesday after the quarterly results but quickly recovered. Shares were up above $95 three weeks ago.
Options Trading News
Related Stories
AGN
Cramer: The pipeline matters most
May 2, 2013
The pharmaceutical business is not about near-term estimates or earnings just reported--it's all about pipeline, what's in the works, what could be blockbuster.
AGN
How the bears are playing Allergan
May 1, 2013
The drug maker broke out to new all-time highs in January and kept climbing through early last month, when it started drifting lower.
Social Media
Follow optionMONSTER for news and updates
Premium Services
-
Semi-active traders looking for simple calls and spreads (5 per week).
Learn More -
Entry-to-mid level traders looking for full circle trade analysis (1 per week).
Learn More -
Tailored, one-on-one education designed and led by Jon & Pete (3 months and up)
Learn More
Education & Strategy
So why do we bother with spreads?
Trading options allows for far deeper levels of complexity than stocks. And while you may never fully venture all the...
